Mary Holland, Esq. & Collyn Peddie, Esq Federal Pre-emption and the Vaccine Act

The U.S. Supreme Court will hear a case this October to decide whether a petitioner in the Vaccine Injury Compensation Program may leave the Program and file a claim for vaccine design defect in a state or federal court. This case, about the DPT vaccine, has relevance for all cases of vaccine design defect and special relevance for the future of thimerosal-induced autism claims. Collyn and Mary will talk about the 1986 statute, the cases leading up to Bruesewitz, and the implications of the Supreme Court’s decision.

Collyn Peddie, Esq. is the principal of her own firm Houston, Texas f rm, specializing in appeals and legal strategy in pharmaceutical, medical device and personal injury cases. Collyn litigated the Bruesewitz v. Wyeth case on behalf of the Williams Kherkher Hart Boundas, LLP fi rm and continues to work on the petitioners’ behalf. She is deeply familiar with legal preemption issues and testifi ed before the Senate Judiciary Committee as “a foot-solder in the ongoing battle over the federal preemption of state pharmaceutical claims” in September 2007.

Mary Holland, Esq. is the managing director of the Elizabeth Birt Center for Autism Law and Advocacy and is also a board member of the Center for Personal Rights and the Coalition for Vaccine Safety. She teaches and NYU Law School and previously practiced private international law and worked for an international human rights organization. She researches and writes on legal issues related to autism and to vaccination.
 

For Zenworks DVD's Policies Please Click Here Zenworks Policies